Pathology

Neoplasia

Unlock FRCOphth Part 1 Study Notes to access this content.

Get access
  • Histologically similar tumours may behave differently within the eye, possibly due to it’s immune privileged status
  • Neoplasm: proliferation of cells that is progressive, purposeless, independent of the surrounding tissue integrity and continues even after the initial stimulus has ceased
  • Malignant tumour (cp benign) are irregular, non-encapsulated, fast-growing and can spread

NB: for more on Retinoblastoma, please refer to the genetics sections

Carcinogenesis

  • Environmental

    • Chemicals
    • Radiation: directly damages DNA leading to mutation
    • Viruses: conjunctival papillomas are caused by HPV 6 and 11 (16 and 18 are high-risk for carcinoma); EBV contributes to orbital Burkitt’s lymphoma
      • HPV produces the E6 protein which binds to and inactivates p53 leading to uncontrolled DNA replication
      • EBV produces a protein that makes the cell resistant to apoptosis
  • Genetic

    • Proto-oncogenes: normal genes that stimulate cell division
    • Tumour suppressor genes: normal genes that inhibit cell division
    • Oncogenes: abnormal/cancerous genes that cause uncontrolled proliferation
    • Loss of both copies of a tumour suppressor gene like Rb is needed for cancer development

Premalignant states

  • Benign tumours: can undergo malignant change possibly after acquiring genetic mutations eg. pleomorphic lacrimal gland adenomas can transform to adenocarcinoma
  • Chronic inflammation: chronic lymphocytic infiltrates in the lacrimal gland associated with Sjogren’s syndrome can develop into lymphoma
  • Intraepithelial neoplasia (carcinoma in situ): actinic keratosis showed pleomorphism and dysplasia and can become squamous cell carcinoma if they breach the basement membrane

Ocular oncology referral guidelines

Who to refer

  • Intraocular tumours

    • Any primary intraocular tumour (except for naevi)
    • Any intraocular metastatic tumour if ocular oncology input required
    • Suspected intraocular lymphoma
  • Conjunctival and epibulbar tumours

  • Conjunctival melanocytic tumours if:

    • Cornea, caruncle or palpebral conjunctiva involved
    • Feeder vessels
    • Nodule with diffuse pigmentation
    • Diameter greater than 3mm, especially in absence of clear cysts
  • Suspicious melanocytic choroidal tumours with

    • Any of

      • Thickness >2mm
      • Collar-stud configuration
      • Documented growth
    • Or two of

      • Thickness >1.5mm
      • Orange pigment
      • Serous retinal detachment
      • Symptomatic
  • Iris nodules if

    • Diameter >3mm
    • Markedly elevated
    • Secondary glaucoma/cataract
    • Angle involvement

Benign tumours

  • Papilloma: benign tumour of an epithelial surface

    • Eyelids:
      • Basal cell papilloma aka seborrhoeic keratosis
      • Squamous cell papilloma: includes molluscum contagiosum (poxvirus) and viral warts (HPV)
    • Conjunctiva: may be pedunculated or sessile (again, associated with HPV)
  • Adenoma: benign tumour of glandular tissue

    • Can arise from eyelid sweat glands, sebaceous glands, meibomian glands
    • Sebaceous adenomas are commonly seen as a yellow mass at the caruncle

Summary table: adnexal malignancy

MalignancyDescription
Basal cell carcinomaRolled-edge, telangiectasia, central ulcer, plaque
Nodular: well-defined islands of basal cells with peripheral palisades
Gorlin-Goltz, Xeroderma pigmentosa, Bazex syndrome, arsenic, Albinism
Imiquimod: immune response modulator stimulates apoptosis
Superficial: discontinuous with buds into dermis
Infiltrative/sclerosing (morphoeic): ill-defined strands of cells
Micronodular: small collections of cells
Squamous cell carcinomaFast-growing, nodular ulcer, papillomatous, keratin horn
Pink cytoplasm, intercellular bridges, keratin pearls.
Sunlight, immunosuppression, AIDS
Lymphatic dissemination (pre-auricular and submandibular nodes)
Spindle cell
Sebaceous cell carcinomaBlepharoconjunctivitis, mimics chalazion, BCC and SCC
Nodular: lobules with foamy/vacuolated cytoplasm
Muir-Torre syndrome (associated with visceral tumours)
Oil red O stains lipid red
Diffuse: pagetoid spread through epithelium
Lacrimal gland neoplasiaProptosis, pain, diplopia
Pleomorphic adenoma: mixed histology, pseudoencapsulated, can transform to carcinoma
Adenoid cystic: cribiform “Swiss-cheese” appearance (aggressive)
Mucoepidermoid
RhabdomyosarcomaProptosis, chemosis diplopia
Embryonal: eosinophilic cytoplasm
Alveolar: poor prognosis
Botyroid

Melanoma

Benign features

  • Absence of mitotic activity
  • No intradermal migration
  • No nuclear enlargement or pleomorphism
  • Melanin in superficial layers but not deep layers

Conjunctival melanoma

  • Premalignant lesions:

    • Primary acquired melanosis with atypia (75% of melanomas): conjunctival intraepithelial melanocytic neoplasia

      • Diffuse flat areas of pigmentation
      • PAM without atypia does not progress to melanoma
    • Pre-existing naevus (20%)

    • De novo: rare

  • Raised pigmented of fleshy conjunctival lesion

  • Metastasizes to lymph nodes, brain and other organs

  • >5mm thickness and forniceal/palpebral or caruncular lesions carry worse prognosis

  • 10% mortality at 5 years, 25% mortality at 10 years

Uveal melanoma

  • Arise from the melanocytes

  • Associated genes:

    • BAP1: most associated with metastasis and mortality
    • SF3B1 and EIF1AX: associated with better prognosis
    • GNAQ and GNA11: no effect on prognosis
  • Relative incidence

    • Iris 8%: slow-growing, nodular tumours. Can cause secondary glaucoma
    • CB 12%
    • Choroid 80%
  • Unilateral

  • Majority are amelanotic

  • Mushroom shaped classically due to subretinal spread after breaching Bruch’s membrane, but may be ovoid or nodular

  • Ocular and oculodermal melanocytosis are associated with increased rate of uveal melanoma (1 in 400 in Caucasians). Due to excessive melanocytes

    • Slate-grey or bluish hyperpigmentation of the sclera (scleral involvement raises risk of glaucoma)
    • Bluish discoloration of periocular skin in the V1 or V2 dermatome
    • Naevus of Ota: both ocular and periorbital skin discolouration (typically unilateral)
  • Complications

    • Exudative retinal detachment
    • Angle closure
    • Neovascular glaucoma (vasoformative factor production)
    • Spontaneous necrosis with symptoms of endophthalmitis
    • Proptosis
  • Histology

    • Callender classification system but can only be used after enucleation

      • Spindle A: cigar-like shaped, slender nucleus, fine chromatin, indistinct nucleolus
      • Spindle B: plumper nucleus and more distinct nucleolus
      • Epithelioid: larger with more pleomorphism. 75% mortality at 15 years
      • Mixed: majority. 50% mortality at 15 years
      • Patterns can be assessed using periodic acid-Schiff stain
    • ISDNA (inverse standard deviation of nucleoli area): newer classification system

  • Macroscopic features

    • Collar studding
    • Orbital spread
    • Subretinal fluid/secondary exudative detachment
    • Orange pigment: lipofuscin
    • Choroidal folds
    • Mushroom-shaped breaks through Bruch’s
  • Prognostic parameters

    • Age

    • Male gender (poorer prognosis)

    • Size (larger basal diameter)

    • Location: CB tumours carry worse prognosis (ie. more anterior location)

    • Cell type: epithelioid type carry worse prognosis

      • Epithelioid: 35% 15-year survival
      • Spindle: 75% at 15 years
    • Closed loop vascular patterns (vasculogenic mimicry patterns) on PAS stain carry worse prognosis

    • Cytogenetics: loss of chromosome 3 heterozygosity (ie. monosomy 3); additional copies of 8q

    • (Chromosome 6p gain is associated with better prognosis)

    • Extrascleral extension leads to metastasis via the vortex veins tributaries

Eyelid melanoma

  • Tumour thickness is the most important prognostic indicator

    • Breslow depth is the thickness from the epithelial surface to the deepest point
      • Melanoma in situ
      • Stage 1: thin/early melanoma (<0.8mm depth)
      • Stage 2: intermediate (0.8-4mm depth). Lymph node biopsy is indicated
      • Stage 2 (still): thick melanoma (>4mm). <50% 5 year survival
      • Stage 3: advanced (spread beyond the original tumour site)
  • Lentigo maligna is the most common type of melanoma (90%)

  • Nodular melanoma is the next most common (10%) [cp. With cutaneous melanoma for which superficial spreading type is most common. In cutaneous melanoma, the subtype does not affect prognosis]

Was this page helpful?

Previous
Cell Growth